The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
There are gaps in the use of therapies that save lives and improve quality of life for patients with heart failure with reduced ejection fraction, both in the US and abroad. The evidence is clear that initiation and titration of guideline-directed medical therapy (GDMT) and comprehensive disease-mod...
Enregistré dans:
Auteurs principaux: | Nicholas K Brownell, Boback Ziaeian, Gregg C Fonarow |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7df8f12bd1b04596939dc345b61dda0f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
par: Neal M Dixit, et autres
Publié: (2021) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
par: Mauro Gori, et autres
Publié: (2021) -
Classification of heart failure: A farewell to ejection fraction?
par: Thomas F. Lüscher
Publié: (2021) -
Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
par: James L Januzzi, et autres
Publié: (2021) -
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
par: Veronika Zach, et autres
Publié: (2020)